• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Yingli Pharma presents a pivotal Phase 2 study data evaluating linperlisib

    PR NEWSWIRE

    Yingli Pharma Announces First Patient Dosed in PII Trial of Linperlisib

    PRNEWSWIRE

    Yingli Pharma, MD Anderson Collaborate for Multiple Oncology Programs

    GLOBENEWSWIRE

    Yingli Pharma Announces presentation on Phase 2 clinical trial of linperlisib

    PRNEWSWIRE

    Yingli Pharma Announces presentation on Phase 2 clinical trial of linperlisib

    PRNEWSWIRE

    Yingli Pharma Announces presentation on Phase 2 clinical trial of linperlisib

    PRNEWSWIRE

    Yingli Pharma to present on the Phase 2 clinical trial of linperlisib

    PRNEWSWIRE

    Yingli Pharma announce promising topline results of a Ph II study

    PRNASIA

    Yingli announce promising topline results of a Phase II study

    PRNEWSWIRE

    Yingli Pharma announce promising topline results of a Ph II registration study

    PRNASIA

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.